USADA suspends Michal Oleksiejczuk one year for testing positive for clomiphene

Michal Oleksiejczuk now has his complete sanctions.

USADA suspended the UFC light heavyweight for one year after his positive test for clomiphene in December, the UFC’s anti-doping partner announced Tuesday. Oleksiejczuk was already suspended one year in March by the Nevada Athletic Commission (NAC) and his win over Khalil Rountree was overturned to a no contest. The suspensions will run concurrently.

Oleksiejczuk, a native of Poland, tested positive for the banned substance — an anti-estrogen agent — in an in-competition drug test in relation to his fight with Rountree at UFC 219 on Dec. 30 in Las Vegas. Oleksiejczuk, 23, initially won by unanimous decision.

His one-year period of ineligibility began retroactively on Dec. 30, 2017, so Oleksiejczuk will be able to return to the UFC on Dec. 29, 2018. Oleksiejczuk (12-2, 1 NC) made his UFC debut against Rountree after his fight with Ion Cutelaba was scrapped at UFC 217 due to Cutelaba’s failed drug test. Oleksiejczuk has won nine straight and is a solid prospect out of Europe.